Invesaro

Stocks Comparison

Fitlife Brands vs Niagen Bioscience: revenue, profit, margins and growth compared

Fitlife Brands brought in $81.5M of revenue in fiscal 2025, Niagen Bioscience $129.4M in fiscal 2025. Revenue changed by +26.4% at Fitlife Brands and +29.9% at Niagen Bioscience on the year before, so Niagen Bioscience grew faster. Fitlife Brands kept 7.8% of its revenue as net profit, Niagen Bioscience 13.4%.

Side by side, latest fiscal year

FTLFNAGE
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$81.5M$129.4M
Revenue growth+26.4%+29.9%
Net income$6.3M$17.4M
Net margin7.8%13.4%
Free cash flow$7.4Mn/a
Free cash flow margin9.1%n/a
Earnings per share (diluted)$0.63$0.20
Cash$1.6M$64.8M
Debtn/an/a
Price to earnings14.715.3
Market value$86.9M$241.3M
Dividend yieldn/an/a
Rank by revenue in sector#318 of 523 · Health care#282 of 523 · Health care

Over the years

Revenue
FTLF FY2018: $17.1MFTLF FY2019: $19.5MFTLF FY2020: $22.1MFTLF FY2021: $27.9MFTLF FY2022: $28.8MFTLF FY2023: $52.7MFTLF FY2024: $64.5MFTLF FY2025: $81.5MNAGE FY2018: $31.6MNAGE FY2019: $46.3MNAGE FY2020: $59.3MNAGE FY2021: $67.4MNAGE FY2022: $72.1MNAGE FY2023: $83.6MNAGE FY2024: $99.6MNAGE FY2025: $129.4MFY18FY19FY20FY21FY22FY23FY24FY25
FTLF $81.5MNAGE $129.4M
Net income
FTLF FY2018: $509KFTLF FY2019: $2.6MFTLF FY2020: $8.8MFTLF FY2021: $5.4MFTLF FY2022: $4.4MFTLF FY2023: $5.3MFTLF FY2024: $9MFTLF FY2025: $6.3MNAGE FY2018: -$33.3MNAGE FY2019: -$32.1MNAGE FY2020: -$19.9MNAGE FY2021: -$27.1MNAGE FY2022: -$16.5MNAGE FY2023: -$4.9MNAGE FY2024: $8.6MNAGE FY2025: $17.4MFY18FY19FY20FY21FY22FY23FY24FY25
FTLF $6.3MNAGE $17.4M
Net margin
FTLF FY2018: 3.0%FTLF FY2019: 13.4%FTLF FY2020: 39.9%FTLF FY2021: 19.4%FTLF FY2022: 15.4%FTLF FY2023: 10.0%FTLF FY2024: 13.9%FTLF FY2025: 7.8%NAGE FY2018: -105.6%NAGE FY2019: -69.4%NAGE FY2020: -33.6%NAGE FY2021: -40.2%NAGE FY2022: -23.0%NAGE FY2023: -5.9%NAGE FY2024: 8.6%NAGE FY2025: 13.4%FY18FY19FY20FY21FY22FY23FY24FY25
FTLF 7.8%NAGE 13.4%
Revenue growth
FTLF FY2019: +14.2%FTLF FY2020: +13.4%FTLF FY2021: +26.2%FTLF FY2022: +3.2%FTLF FY2023: +83.0%FTLF FY2024: +22.3%FTLF FY2025: +26.4%NAGE FY2019: +46.7%NAGE FY2020: +28.0%NAGE FY2021: +13.8%NAGE FY2022: +6.8%NAGE FY2023: +16.0%NAGE FY2024: +19.2%NAGE FY2025: +29.9%FY19FY20FY21FY22FY23FY24FY25
FTLF +26.4%NAGE +29.9%
Free cash flow
FTLF FY2018: $258KFTLF FY2022: $4.1MFTLF FY2023: $4.1MFTLF FY2024: $9.6MFTLF FY2025: $7.4MNAGE FY2018: -$22.2MNAGE FY2019: -$21.2MFY18FY19FY22FY23FY24FY25
FTLF $7.4MNAGE -$21.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Fitlife Brands and Niagen Bioscience

Which is bigger by revenue, Fitlife Brands or Niagen Bioscience?

Niagen Bioscience is bigger by revenue: $129.4M in fiscal 2025, against $81.5M for Fitlife Brands in fiscal 2025.

Which keeps more of its revenue as profit, Fitlife Brands or Niagen Bioscience?

Fitlife Brands had a net margin of 7.8% in fiscal 2025; Niagen Bioscience had 13.4% in fiscal 2025.

Which grew revenue faster, Fitlife Brands or Niagen Bioscience?

In their latest fiscal years revenue changed by +26.4% at Fitlife Brands and +29.9% at Niagen Bioscience.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies